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Pathway-Focused Arrays Reveal Increased Matrix
Metalloproteinase-7 (Matrilysin) Transcription in
Trachomatous Trichiasis
Martin J. Holland,1,2 David Jeffries,2 Michael Pattison,2 Gerit Korr,1 Alevtina Gall,2
Hassan Joof,2 Ahmed Manjang,2 Matthew J. Burton,1 David C. W. Mabey,1
and Robin L. Bailey1
PURPOSE. Several genes that are associated with protection from
or susceptibility to trachomatous trichiasis (TT) have been iden-
tified through genetic association studies. Yet there have been
few studies in which gene expression profiles were assessed in
TT cases and disease-free controls. The purpose was to identify
genes that are differentially expressed in the upper tarsal conjunc-
tiva of subjects with TT.
METHOD. Pathway-focused gene arrays were used to screen
conjunctival RNA expression of 226 gene transcripts of inter-
est. The screening was followed by validation of differentially
expressed genes by qRT-PCR on an independent set of sam-
ples. Three different techniques were then used to test for
quantitative differences in the recovered conjunctival protein
fraction.
RESULTS. Focused arrays identified a set of 13 differentially
expressed genes. Validation by qRT-PCR confirmed differential
expression in four of these genes (COL1A1, COL7A1, MMP7,
and TLR6). Increased expression of MMP7 was the only con-
sistent differentially regulated gene in the conjunctival samples
of trichiasis subjects. MMP7 was present in isolated conjuncti-
val proteins and in the tissue culture supernatants of peripheral
blood lymphocytes after stimulation.
CONCLUSIONS. There is an imbalance in extracellular matrix
turnover with minimal contribution of adaptive immune re-
sponses at this stage of trichiasis. There was little evidence of
broad differential expression in genes characteristic of polar
responses of adaptive T cells or macrophages. The control of
the MMP7 response and its activity appears significant in the
fibrotic changes observed in TT. (Invest Ophthalmol Vis Sci.
2010;51:3893–3902) DOI:10.1167/iovs.09-5054
Trachoma, a disease caused by infection with Chlamydiatrachomatis, is now predominantly found in the develop-
ing world. Recurrent infection with this bacterium leads to
inflammation of the upper tarsal conjunctiva and eventually to
scarring. Progressive scarring over time leads, in some individ-
uals, to trachomatous trichiasis (TT), a morphologic change in
the eyelid causing the lashes to rub against the globe. This
process, which often occurs in the absence of detectable C.
trachomatis infection, can result in corneal opacity and blind-
ness.1 An estimated 40 million currently have active trachoma.
Of those, 8.2 million have TT, and 1.3 million are irreversibly
blind as a result.2
The SAFE strategy is recommended by the World Health
Organization (WHO) for the control of blinding trachoma:
surgery for trichiasis, antibiotics for infection, facial cleanli-
ness, and environmental improvements to reduce transmission
of infection. However, since fibrosis may continue to progress
in the absence of current C. trachomatis infection, new cases
of TT are likely to be seen in endemic communities after
transmission of C. trachomatis has been controlled. Even after
successful surgery, recurrence rates of up to 60% may be seen
within 3 years.3 It is therefore important to understand the
processes involved in the pathogenesis of TT by gaining a more
complete understanding of the tissue-specific responses asso-
ciated with the disease process.
It is well established that T helper type 1 (Th1) cells are
associated with clearance of chlamydial infection.4,5 In partic-
ular, IFN plays an important role in the clearance of chlamyd-
ial infection in both mice and humans.6,7 However, the inflam-
matory response, to which IFN contributes, may also be the
cause of disease if it is excessive or uncontrolled. Normally, the
inflammatory response is counterbalanced by IL-10.8,9 More
recently, regulatory T cells (Tregs) have been identified as impor-
tant counterinflammatory mediators of disease in several chronic
infections, especially at the site of infection.10,11 Tregs, which can
be identified in the conjunctiva during ocular viral infection, may
also play a part in the pathogenesis of trachoma.12,13 Additional
counterbalancing mechanisms include the evolution of Th2 or
type-2 responses. Type 2 responses are frequently associated
with chronic inflammation and infection. Although there is
some evidence that Th2 responses are contributory to chlamy-
dia’s effects,6,8,14 there is little convincing evidence that polar
Th2 cell responses directly cause fibrosis.
On the other hand, the role of innate responses from epi-
thelia and leukocytes are increasingly recognized as playing an
important role in the pathologic inflammatory process. In par-
ticular, IL1 and -8 have both been identified in vitro (from C.
trachomatis–infected cells15) and in vivo (from trichiasis pa-
tients with inflammation16,17), leading to the suggestion that
these are critical factors in the development of inflammatory
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disease. There is now a much improved understanding of the
interaction of innate responses, autoinflammatory cascades,
and tissue homeostasis. In particular, the interaction of the
matrix metalloprotease (MMP) family of proteins, proinflam-
matory cytokines, and innate antimicrobial peptides produced
by T cells, NK cells, and macrophages.
Thus far, the investigation of the cellular responses and ECM
composition of the conjunctiva or the tear film constituents of
patients with trichiasis is limited to a few immunohistochemical
and expression studies.17–21 Therefore, we investigated whether
the expression of other genes involved in innate, adaptive, and
extracellular matrix regulation were altered in conjunctival tissue
from participants with TT. We show that at this stage of disease,
in the almost complete absence of current chlamydial infection,
there is little evidence of the involvement of factors produced by
the specific adaptive immune response. The profile of responses
is characterized by a dominance of gene expression of innate
defense molecules and ECM components. In particular, the al-
tered expression of MMP7 appears strongly associated with fi-
brotic disease.
METHODS
Study Participants and Samples Collected
Informed consent was obtained from all study participants. The par-
ticipants were recruited from rural and semi-urban areas within the
Western and Lower River Regions of The Gambia. Trachoma was
graded by a single experienced field supervisor according to the World
Health Organization (WHO) simplified grading system. Subjects with
TT (more than one eyelash touching the globe) were identified. For
each TT case, an age-, sex-, and location-matched control subject
without any signs of conjunctival scarring and who was not a member
of the same family was also recruited. Participants were age matched
within 5 years of one another. In a standardized manner, an ocular
swab from the everted tarsal conjunctiva of each participant was
collected into RNA stabilizer (RNAlater; Ambion Europe, Ltd., Hunt-
ingdon, UK) for the isolation of proteins and nucleic acids. Venous
blood samples were obtained from a subgroup of these subjects. The
study was conducted in accordance with the tenets of the Declaration
of Helsinki. It was approved in The Gambia by the joint Ethics Com-
mittee of the Gambian government and the U.K. Medical Research
Council and by the ethics committee of the London School of Hygiene
and Tropical Medicine.
Isolation of DNA, Total RNA, and Total Protein
from Ocular Swabs
Total RNA was isolated (RNeasy micro kits; Qiagen, Ltd., Crawley, UK)
and used as a template to generate probes for miniarrays (SuperArray;
Qiagen, Ltd.). Total RNA was eluted in 30 L of RNase-free Tris. The
total yield and purity of nucleic acid in Tris was estimated by spectro-
photometer (NanoDrop ND-1000; Thermo Scientific, Wilmington, DE).
RNA samples with low purity (260:2801.8) or with evidence of
impurities from the extraction procedure (230:2601.8) were re-
extracted by repetition of the extraction protocol with the addition of
a twofold increase in wash buffers. These were then reassessed for
purity and quantity. Only samples that had a spectrographic profile
consistent with those outlined at the Genome Center Maastricht
(RNA quality control: NanoDrop ND-1000; Thermo Scientific;
http://biomedicalgenomics.org/RNA_quality_control.html) were used
for the production of biotin UTP labeled-aRNA. Samples from 11 cases
and controls with at least 100 ng total RNA were used as templates to
generate aRNA. Assessment of the quality of RNA by microcapillary
gels was not available. All subsequent ocular swab samples were
extracted (All-Prep Kit; Qiagen, Ltd.), according to the manufacturer’s
instructions. To obtain maximum yields of DNA, RNA and protein from
the ocular swabs, a modified initial step was used. Swabs were trans-
ferred to a 2-mL screw-cap tube containing sample lysis buffer. They
were then vortexed vigorously and the swab discarded. The lysate was
passed through a column that binds DNA. The column was washed,
and the DNA was eluted in 100 L of RNase-free water. Ethanol was
added to the flow-through from the DNA column and added to a
minispin column (RNeasy; Qiagen, Ltd.). Total RNA bound to the
membrane was subjected to DNase I digestion. The total RNA was
eluted in 60 L of RNase-free water. Proteins were precipitated from
the flow-through with buffer APP. The precipitated proteins were
collected by centrifugation, and total protein was redissolved in 100 L
of 5% sodium dodecyl sulfate (SDS). DNA and protein samples were
stored at 20°C and RNA at 70°C.
Quantification of Total Amounts of Nucleic Acid
and Protein
Total RNA was quantified in a 2-L sample by reading the absorbance
at 260 nm (NanoDrop model ND-1000; Thermo Scientific). Total DNA
was quantified by measuring the amount of mitochondrial DNA
present in the sample using SYBR-green qPCR. Total protein was
quantified in 10-L samples with an enhanced bicinchoninic acid
(BCA) assay (Pierce Chemical, Rockford, IL) on the spectrophotometer
(NanoDrop ND-1000; Thermo Scientific).
Generation of Labeled aRNA Probes and Gene
Array Analyses
Total RNA was amplified and labeled with biotin-UTP (Message Amp II
kit; Ambion Europe Ltd.). Biotin-labeled aRNA was produced after two
overnight rounds of in vitro transcription. Labeled aRNA was hybrid-
ized overnight to each membrane and two separate membranes (ar-
rays) were used for each subject (with the exception of one sample
from an affected case on one Th1/Th2/Th3 array). All arrays, hybrid-
ization solutions, wash, and probe detection kits were purchased
(SuperArray Bioscience Corp., Frederick, MD). Each array consisted of
113 genes (two blanks, three artificial sequences, one bacterial plasmid
sequence [PUC18], two biotin-coupled positive controls, and five ref-
erence genes covering seven positions) that were selected for involve-
ment in pathways focused on human extracellular matrix and adhesion
molecules (OHS-013) or human Th1/Th2/Th3 cells (OHS-034). Bound
aRNA was detected by the addition of streptavidin-alkaline phospha-
tase (CDP-Star; Roche Diagnostics, Indianapolis, IN). Images of the
membranes were captured with a chemiluminescence detection
system (Chemi-Doc; Bio-Rad Laboratories, Ltd., Hemel Hempstead,
UK) with a CCD camera after 100 seconds of exposure for ECM
arrays and 200 seconds for Th1/Th2/Th3 arrays. Each 16-bit TIFF file
was then downloaded into array-analysis software (GEArray Expres-
sion Analysis Suite 2.0; SuperArray) for image processing and array
analysis. Local background correction for spot intensity was applied
to each membrane and the raw spot intensities values were then
exported to a spreadsheet along with all array meta-information
(Excel; Microsoft, Redmond, WA). The raw spot intensities, images,
and array information were then analyzed by using the image-
processing and array tool features in commercial software (MatLab;
The MathWorks, Natick, MA).
Array Normalization
We tested 11 different array normalization strategies, the most appro-
priate array normalization method was selected by testing each nor-
malization with the technique described by Kroll and Wolfl.22 Normal-
ization of the arrays with the global mean was selected as the best
fitting normalization method. The filtered gene list of significantly
differentially regulated gene transcripts was then produced based on
rank differences in signal intensities. A distribution-free test of signifi-
cance based on rank difference was used. Genes with rank differences
which were significant at the 10% level, without adjustment of P-values
for multiple testing, were considered differentially expressed. Only
those in which at least five subjects had above-background expression
values were selected for further analysis. Since multiple array normal-
ization strategies were tested, only genes that appeared in global mean
3894 Holland et al. IOVS, August 2010, Vol. 51, No. 8
normalization and at least one of the other 10 normalization strategies
tested were selected. Reproducibility and consistency between arrays
was tested with a rank-based ANOVA. Last, a categorical nonquantita-
tive analysis, based on presence or absence scoring, was also per-
formed. These categorical data were analyzed by Fisher’s exact test,
and the results used to complement the quantitative analysis of differ-
ential gene expression. We calculated the percentage of false-positive,
differentially expressed genes at the 10% and 5% level according to the
method described by Stekel.23
Quantitative RT-qPCR
The PCR primer sequences used in this study are listed in Supplemen-
tary Table S1 (all Supplementary Tables are available at http://www.
iovs.org/cgi/content/full/51/8/3893/DC1). qRT-PCR was performed
using a two-step protocol previously described.24 Gene expression was
quantified in duplicate by real-time qPCR (QuantiTect SYBR Green PCR
kit; Qiagen, Ltd.) on a real-time thermal cycler (Rotor-Gene 6000;
Corbett Research, Cambridge, UK). Standard curves were used to
quantify the copy number in unknown or test samples, as described by
Burton et al.20
Mitochondrial DNA qPCR
PCR was performed on genomic DNA with primers for human-specific
hypervariable 1 (HV1) D-loop region mitochondrial DNA in conditions
described by Harding-Esch et al.25 The amount of DNA in the sample
was then expressed as follows: The sample with the highest cycle
threshold (Ct1) was selected as the reference, and all other samples (n)
were then estimated relative to this value by multiplying it by two to
the power of the difference in the cycle threshold [Ct1  2(Ct1 Ctn)].
Testing for C. trachomatis
A commercial assay (Amplicor CT/NG; Roche Diagnostics) was used
for detection of C. trachomatis in cases and controls, as described
elsewhere.26 The reaction buffer conditions required were attained by
first diluting purified DNA (9 L) in 94.5 L of a 50:50 mixture of lysis
and diluent buffers; 50 L was then used in the standard assay. Positive
and negative samples were assigned according to the manufacturer’s
instructions.
SDS-PAGE, Silver Staining, and
Immunoblot Analysis
Total protein was pooled from each of the cases and controls, and 10
g of protein was denatured by boiling in SDS-PAGE gel-loading buffer
and loaded onto 5% to 15% polyacrylamide gradient gels (Bio-Rad
Laboratories, Ltd.). Ten microliters of protein-marker IV (peqGOLD;
Peqlab, Erlangen, Germany) was loaded as size markers. Total protein
in SDS-PAGE gels was visualized by staining (ProteoSilver kit; Sigma-
Aldrich, Poole, UK), per the manufacturers’ protocol. Immunoblots
were prepared as just described after the transfer of proteins from the
SDS-PAGE gel to nitrocellulose membranes. The membranes were then
preblocked in a TBS-T (Tris-buffered saline, 0.1% Tween) supple-
mented with 5% powdered milk solution overnight at 4°C before
immunoblot analysis. The membranes were incubated with a primary
anti-MMP7 antibody (MAB9071; 1:100; R&D Systems Europe Ltd,
Abingdon, UK), followed by a secondary anti-mouse IgG horseradish
peroxidase–conjugated antibody. Bound antibodies were detected
with enhanced chemiluminescence (ECL Plus; GE Health Care, Amer-
sham, UK), according to the manufacturer’s instructions. Chemilumi-
nescent output was then visualized with a 1-minute exposure using
standard x-ray film. The films were photographed and scanned by a gel
documentation system and analyzed (Gel-doc with Quantity-one soft-
ware; Bio-Rad Laboratories, Ltd.).
In Vitro Culture and Stimulation of PBMCs
PBMCs were isolated and cultured as described elsewhere.27 The cells
were co-incubated with 5 g/mL of pokeweed mitogen (PWM), sero-
var A C. trachomatis elementary bodies (EBs), or culture medium
alone. The cells were cultured for 7 days. On day 6, 100 L of culture
supernatant was removed from each well, followed by the addition of
1 Ci/well [3H]thymidine for the last 18 hours of culture, to determine
the proliferative index. The culture supernatant was frozen at 20°C
until tested for cytokines by capture ELISA.
MMP7 Capture ELISA
MMP7 ELISA kits (Quantikine; R&D Systems) were used to measure
amounts of pro- and active MMP7 according to the manufacturer’s
instructions for tissue culture supernatants. PBMC culture supernatants
from 30 cases and controls stimulated for 6 days with pokeweed
mitogen, C. trachomatis A EBs, or culture medium alone were tested.
The quantity of MMP7 in nanograms per milliliter was then estimated
from a standard curve performed at the time of the assay for each plate.
The sensitivity of the assay was 0.094 ng/mL.
Statistical Analysis
For qRT-PCR and ELISA, a matched-pair analysis was performed using
the Wilcoxon signed-rank test. For assays below sensitivity, the data
were reclassified as positive or negative, and the pairing was main-
tained by using McNemar’s 2 test. We did not estimate the power of
the study since, in the absence of any previous studies, it was not
possible to estimate the size of the expected differences or the number
of genes in a particular pathway that might be affected. Unadjusted
P-values after multiple testing are presented with the significance level
expected after Bonferroni correction.28
RESULTS
Study Group and Sample Characteristics
Table 1 describes patient and sample characteristics of the
individuals participating in the different parts of the study.
Eleven case–control pairs were studied with gene microarrays
(SuperArray), and a further 47 case–control pairs were studied
with qRT-PCR. Cases and controls were matched on age, sex,
location, and ethnicity, which act as a proxy control for infec-
tion exposure history but without the development of scarring
disease. Only one case tested positive for C. trachomatis in-
fection. Nucleic acid and proteins were isolated from the
swabs of these subjects and the levels estimated by using the
different assays. The levels of each of these fractions were not
significantly different between the cases and controls and in-
dicated no inherent fundamental differences or technical in-
consistencies that might later affect measurements of differen-
tial gene expression. The total number of genes expressed on
each array by each group of cases or controls was extracted
from the arrays. No large-scale or significant differences were
indicated in the total number of genes expressed between the
cases and controls. This lack of significance suggested that the
comparison of healthy to diseased tissue expression was ap-
propriate and that altered expression levels of genes normally
expressed in the conjunctiva, rather than aberrant gene expres-
sion, contribute to the pathologic changes observed.
Genes Involved in ECM Breakdown, Remodeling,
and Adhesion
The conjunctival RNA samples of 22 subjects in total, repre-
senting 11 case–control, pair-matched samples, were tested on
both the ECM and adhesion molecules array and on the Th1/
Th2/Th3 array. There was a sufficient yield of aRNA from one
sample after amplification to probe only the ECM array. The
array platform layout and differential gene expression across
the sum of these arrays is visually represented in Figure 1.
Genes that were significantly differentially expressed from
both array types are shown in Table 2, including accession
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numbers and brief descriptions of gene product function. In
total, nine genes were considered significantly upregulated,
and three were downregulated in the TT cases compared with
the controls. One additional gene (COL1A1) was identified as
significantly more frequently expressed in the TT cases than in
the controls based on categorical scoring of spot presence or
absence (Supplementary Table S2). The signal intensities of
these spots are close to background. At P  0.1 or  0.05, the
number of potential false-positive genes with differential gene
expression was calculated as 24 and 0.6, respectively. The raw
acquired images of the developed arrays are shown in Supple-
mentary Figure S1 http://www.iovs.org/cgi/content/full/51/8/
3893/DC1, and tables of the raw and background spot intensity
values are given in Supplementary Table S3. There were no
significant differences between the cases and controls in the
total number of genes expressed on each type of array (refer-
ence genes and control sequences were excluded). A simple
summary table of the genes expressed in the extracted con-
junctival RNA is shown in Supplementary Table S4.
Validation of Differentially Expressed Genes in
Total RNA from Ocular Swabs from an
Independent Set of TT Subjects and Controls
Initially, human ribosomal protein 1 (HuPO1), used in several
other studies as a housekeeping gene,29,30 was selected as a
reference gene for qRT-PCR normalization. However, the
HuPO1 copy number per nanogram total RNA was not equal in
cases and controls (data not shown) and so was disregarded. As
an alternative normalization method, the amount of total RNA
or DNA, which was not significantly different between cases
and controls, was selected. Normalization by either of these
latter measures was considered suitable, since these had min-
imal effects on the correlation structure of the data and have
been used by others.31,32 Real-time quantitative PCR was then
used in a larger set of independent samples to determine
whether the 14 genes identified from the array screening
would be differentially expressed when assayed with nonam-
plified total RNA as the starting template. Assays with sufficient
specificity and sensitivity for COL19A1 were not developed.
Three additional genes, ARG1, CCL18, and NOS2, characteris-
tic of M1/M2 macrophage polarization, were screened at this
stage (Fig. 2). Four genes were significantly differentially ex-
pressed (P  0.05). MMP7 was upregulated and consistent
with the array results, whereas COL1A1, COL7A1, and TLR6
were all found to be downregulated in cases by qRT-PCR and
were inconsistent with array results. The assays of four genes
(VCAN, LAMB1, SOCS1, and NFATC1) were not sensitive
enough to provide sufficient quantitative data, and the results
were therefore reclassified categorically as responder or non-
responder and analyzed by McNemar’s 2 test. None of the
four genes was significantly differentially expressed between
groups when analyzed in this way. Most of the genes identified
from the array and tested by qRT-PCR (n  7/12) were con-
sistent in their expression. MMP7 was the only gene that was
consistent in its significant differential expression by array and
by qRT-PCR and was frequently identified as differentially ex-
pressed, irrespective of the array normalization method se-
lected. We therefore focused on MMP7 expression in the
recovered conjunctival protein fraction and on its production
by in vitro cultured PBMCs stimulated with chlamydial antigens
from the cases and controls.
SDS-PAGE Resolution of Isolated
Conjunctival Proteins
Silver staining was used to visualize the total protein content
recovered from the conjunctival swabs of the cases and con-
trols in SDS-PAGE gels (Fig. 3). The proteins were pooled from
each of the 47 cases and controls, and equivalent amounts of
protein were loaded on the gel. No gross differences in the
number or the intensity of the protein bands were evident.
Overall, the cases and controls appeared to have nine major
bands. A dominant, intense band at 60 kDa was present in
both groups. The gels were analyzed (Quantity-one software;
Bio-Rad) and produced a density profile that suggested a small
change between the cases and controls in abundance of pro-
teins below the major band at 60 kDa.
TABLE 1. Participant Characteristics for Each Part of the Study
Cases Controls
Gene Array Samples
Age (range), y 67 (49–80) 65 (44–80)
Sex
Male 3 3
Female 8 8
Total RNA yield (ng/L) 18.72 (8.4–63) 15.8 (10.2–64.4)
CT/NG Amplicor NT NT
Median number (range) of genes expressed
per array type
ECM 40 (29–64) 49 (36–65)
Th1/Th2/Th3 33 (19–55) 48 (21–63)
qRT-PCR Samples
Age (range), y 54 (3–76) 50 (3–75)
Sex
Male 22 22
Female 25 25
Total RNA yield (ng/L) 13.75 (6.4–29.2) 13.64 (2.9–22.8)
Total DNA* (qPCR) 3300 (67–13790) 3536 (27–39840)
Total protein (ng/L) 309.8 (100–794) 331.4 (119–791)
CT/NG Amplicor (n positive) 1 0
n  11 for both cases and controls for Gene Array; n  47 for both groups for qRT-PCR. Data are
expressed as median (range). NT, not tested.
* Below measurable range (2 ng/L) of the spectrometer (OD 280 nm) and therefore estimated by
relative quantification real-time PCR.
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Detection of MMP7 in Recovered Conjunctival
Proteins by Immunoblot Analysis
The molecular weight of pro-MMP7 is 28 kDa; however, the
recombinant hMMP7 (MMP7 Quantikine kit; R&D Systems) is
produced in carrier formwith a larger molecular weight. Figure 4,
lane 2, shows a large band at 70 kDa when probed with
anti-MMP7 that served as a positive control reaction. When
probed with secondary antibody alone (lane 3) there was no
reactivity. A band of equal intensity was visible in lanes 4 (pooled
cases) and 6 (pooled controls) at 26 kDa, when probed with
monoclonal anti-MMP7 antibody. No bands were visible in lanes 5
(pooled cases) and 7 (pooled controls) when probed with sec-
ondary antibody alone.
Quantification of MMP7 by Quantikine
Capture ELISA
Since quantitative differences between the cases and controls
could not be determined with immunoblot analysis, we at-
tempted to measure MMP7 levels in the individual samples of
recovered conjunctival proteins and in PBMC tissue culture
supernatants. PBMCs were used as a source of cells that ex-
press abundant levels of MMP7, to complement the estimates
of MMP7 levels directly recovered from the conjunctival pro-
teins. However, the levels of MMP7 could not be measured in
recovered total conjunctival protein collected from ocular
swabs because of the inhibition of the assay by the samples.
MMP7-spiked samples remained inhibited despite dilution of
the samples and exchange of sample in appropriate buffers and
diluents. MMP7 levels in culture supernatant of PBMCs appear
to accumulate over time since at 2 days after culture, levels
were not detectable (data not shown). By 6 days of culture
spontaneous production of MMP7 in unstimulated cultures was
highest in both the cases and controls, although highly variable
(Fig. 5). Stimulation with either PWM or EBs inhibited or
blocked the spontaneous production of MMP7 by PBMCs. This
difference in levels reached borderline significance in response
to stimulation with EBs, such that in the cases, stimulation with
EBs had a smaller effect on the inhibition of MMP7 production
than in the controls. The degree of inhibition or the amount of
a b
c d
FIGURE 1. Total RNA was isolated from conjunctival swabs of 11 trichiasis cases and 11 age-, sex-, and location-matched controls. mRNA was
amplified, biotin labeled, and used as a probe on each array. The array layouts with gene symbols are shown in (a) for ECM and cell adhesion
molecules and in (c) for Th1/Th2/Th3. (b, d) Genes in which the rank difference was significant at the 10% level are indicated by their designated
gene symbol. (Red) Genes with increasing intensity of expression; (green) decreasing intensity of expression between cases and controls for each
array type.
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MMP7 production did not correlate (positively or negatively)
with either the PBMC proliferative index or production of IFN
(data not shown).
DISCUSSION
We investigated conjunctival gene expression in subjects with
TT using low-density, focused gene expression arrays and qRT-
PCR, targeting the genes involved in inflammation and ECM
composition. Validation of focused array data by RT-PCR con-
firmed the differential expression of genes involved in ECM
regulation (MMP7, COL1, and COL7) and innate immune re-
sponses (TLR6), but only MMP7 expression was consistent
between results obtained with arrays and qRT-PCR. There was
no evidence from qRT-PCR of differential regulation of Th2
transcription factors, NK2 cell markers, or suppression of IFN
signaling by SOCS1. The addition of CCL18, NOS, and ARG to
TABLE 2. Differentially Expressed Genes Identified from ECM and Th1/2/3 Arrays
Gene Symbol
Accession
No.* Gene Name (Function)
Change
Ratio†
Rank
Difference P
Extra Cellular Matrix and Adhesion Molecules
Upregulated
COL7A1 NM_000094 Collagen, type VII, alpha 1 (Adhesion molecule, basement
membrane constituent, ECM structural constituent, ECM
protease inhibitor)
0.94 3.36 0.0981
COL9A1 NM_001895 Collagen, type IX, alpha 1 (Adhesion molecule, ECM
structural constituent)
1.34 3.00 0.0695
COL19A1 NM_001858 Collagen, type XIX, alpha 1 (Cell-cell adhesion, ECM
structural constituent)
0.99 3.00 0.0695
MMP7 NM_002423 Matrix metallopeptidase 7 (ECM protease, epithelial cell
inflammatory response to virulent bacteria, activation of
-defensins and other innate factors)
4.30 5.00 0.0665
VCAN NM_004385 Versican (Basement membrane connective tissue link
protein, tumour metastasis)
1.30 4.45 0.0404
Downregulated
COL12A1 NM_004370 Collagen, type XII, alpha 1 (Adhesion molecule, ECM
structural constituent)
0.53 3.00 0.0695
LAMB1 NM_002291 Laminin, beta 1 (Structural basement membrane protein) 0.79 3.00 0.0695
Th1/Th2/Th3
Upregulated
NFATC4 NM_004554 Nuclear factor of activated T cells, cytoplasmic, calcineurin
dependent-4 (Th2 and induction of IL4 and IL2)
1.84 4.77 0.0783
SOCS1 NM_003745 Suppressor of Cytokine signaling 1 (Th1 cytokine induced
inhibition of IFN signaling)
1.54 5.92 0.0262
TLR6 NM_006068 Toll-like receptor 6 (innate inflammatory response to
bacterial lipoproteins with TLR2)
1.34 4.20 0.0763
TMED1 NM_006858 Transmembrane emp24 protein transport domain containing
1 (Th2, NK2 and NKT2 surface-expressed marker)
2.36 6.11 0.0242
Downregulated
NFATC1 NM_172390 Nuclear factor of activated T cells, cytoplasmic, calcineurin
dependent-1 (Th2 cytokine gene expression)
0.37 3.92 0.0399
* http://www.ncbi.nlm.nih.gov/Genbank; provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD.
† Change ratio of expression derived from raw non-normalized values from the array. Percentage of false positives at P 0.05 15; P 0.1 100.
FIGURE 2. Median difference (with upper or lower quartile range) in
relative expression from total RNA conjunctival samples of 47 cases
and 47 controls measured by qRT-PCR with primers specific for each
gene. Positive differences indicate an upregulation in disease and
negative differences indicate a reduction in expression. Unadjusted
significant P-values (P  0.05), shown above each target gene, were
calculated with Wilcoxon-signed rank test. Bars indicate significantly
downregulated genes. Bonferroni correction for multiple testing esti-
mates significant values needed to reach 0.05/16 (P  0.003125).
FIGURE 3. Conjunctival protein fraction from pooled cases (10 g)
and pooled controls (10 g) run on 5% and 15% SDS-PAGE silver-
stained gels. Density profiles are shown to the right of each lane,
indicating a small change in profile shape and height below the major
60-kDa band (arrows).
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screen for macrophage polarization found no evidence of po-
larization.
MMP7 upregulation is widely found in other fibrotic dis-
eases and tumor metastasis.33,34 MMP7 is naturally expressed
in epithelia and injured tissue35 and is increased in alternatively
activated (M2) macrophages.36,37 MMP7 has a wider role than
ECM regulation, with an increasingly recognized position in
innate defense by its action on latent TNF, -defensins, and FAS
ligand.38–40 Mice deficient in MMP7 (mmp7/) that lack
functional intestinal -defensins are highly susceptible to infec-
tion by enteric pathogens. They also have reduced levels of
active FAS ligand and epithelial cell apoptosis. Furthermore,
MMP7 is crucial in establishing chemokine gradients;
mmp7/ mice are unable to effectively recruit neutrophils to
sites of pathogen entry or tissue damage,41 suggesting an im-
portant role in inflammation. It is also responsible for activa-
tion of pro-TNF on macrophages42 and has been identified as a
biomarker of idiopathic pulmonary fibrosis.43
The role of MMPs in Chlamydia-induced diseases has been
studied. MMP9 has received the most attention after reports
that indicated increased conjunctival expression20,24 and enzy-
matic activity18 in trachoma patients. As yet, there are no small
rodent models of ocular chlamydial infection that can repro-
duce the chronic changes observed in the human conjunctiva.
Urogenital infection of the mouse offers the next best approx-
imation in small rodents and does induce the expression of
MMPs (MMP2, -9, and -1244). Administration of chemical inhib-
itors of MMPs protected mice from ascending infection and
hydrosalpinx.45 Subsequent experiments in MMP9KO mice
demonstrated that the ablation of MMP9 production was suffi-
cient in this model to prevent the pathologic changes associ-
ated with ascending genital infection.46 Changes in MMP7
levels have not been directly reported in response to chlamyd-
ial disease, although the effect of infection in MMP7KO mice
has been studied in relation to sequelae and the immune
response. Deficiency in MMP7 had little effect on the magni-
tude or duration of infection, fertility rates, and hydrosalpinx
formation,47 leading the authors to conclude that MMP7 was
not a requirement in the progression or resolution of chlamyd-
ial infection in this model. However, the natural history of
ocular infection in humans is markedly different from that in
murine genital tract models of infection; thus, the contribution
of MMP7 to fibrosis in trachoma is likely the result of repeated
or prolonged inflammatory insults, which are often associated
with colonization with multiple bacterial species.
MMP7 is one of several genes whose expression is con-
trolled via Wnt (wingless, int) signaling. At least seven recog-
nized terminal target genes of canonical Wnt signaling have
been identified in fibrosis (BMP, MYC, CD44, NOS2, MMP7,
PPAR, and FN1).48 Four of these genes (CD44, NOS2, MMP7,
and FN1) were upregulated in TT cases on the array. A limited
number of genes involved in the Wnt signaling pathway were
covered on the array, some of which are involved in E-cadherin
signaling and the maintenance of the epithelial cell barrier.
Immune-mediated fibrotic diseases, such as schistosomula-
induced hepatic fibrosis, are dominated by Th2-cytokine re-
sponses where IL13 and the decoy receptor IL13R2 are key.49
IL-11 and its receptors are also clearly identified as playing a
significant role in some immune-mediated fibrotic diseases.50
More recently polarized macrophages that favor deposition of
collagens and fibrosis have been demonstrated to be important
in the development of disease (e.g., pulmonary fibrosis51 and
responses to chronic helminth infection52). There was no
evidence of Th1/Th2/Th3 polarization, although altered ex-
pression of NFATC1/4, SOCS1, and TMED1 may suggest some
evidence of inhibition of IFN signaling and stimulation of Th2,
NK2 cells. We did not identify any of the factors found in
previous studies on trichiasis patients as having significantly
altered expression (IL1B, TNF,MMP1:TIMP1). Nor were genes
FIGURE 5. Production of MMP7 (ng/mL) in tissue culture supernatants
collected from cases and controls. Freshly isolated PBMCs from cases
or controls were cultured with PWM, serovar A EBs, or culture medium
alone for 6 days. Production of MMP7 by cells in culture medium alone
was the highest in both cases and controls. Stimulation with either
PWM or EB inhibited the spontaneous production of MMP7 by PBMCs.
This difference in levels reached borderline significance in response to
stimulation with EBs, such that in cases (median [IQR]  0.48 [1.52–
0.35] ng/mL) stimulation with EBs has a lesser effect on the inhibition
of MMP7 production than in controls (median [IQR]  0.35 [0.62–
0.128] ng/mL).
FIGURE 4. Immunoblot using conjunctival proteins recovered from
cases and controls. Total pooled proteins (10 g) were transferred to
nitrocellulose membranes and probed with an anti-MMP7 primary (1°)
antibody. Bound antibody was detected with a secondary (2°) antibody
conjugated to HRP (anti-mouse IgG-HRP) and detected by ECL. Control
lanes were probed with 2° antibody alone. Molecular weight markers
were used in lane 1 to estimate the size of unknown bands from
pooled samples. Lanes 2 and 3 were loaded with 0.1 ng of recombi-
nant human MMP7 (rhMMP7) as a positive control (70 kDa when
probed with anti-MMP7). Probing with 2° antibody alone (lane 3)
elicited no reactivity. A band at26 kDa was visible in lanes 4 (pooled
cases) and 6 (pooled controls) when probed with monoclonal anti-
MMP7 antibody. No bands were visible in lanes 5 (pooled cases) and
7 (pooled controls) when probed with 2° antibody alone.
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that have been identified in other infection or immune-driven
fibrotic diseases differentially expressed. This does not rule out
the involvement of these genes in the disease process. The
small number of subjects studied and the sensitivity of the array
could account for the lack of differences. In addition, the
simplified WHO grading system used to identify cases and
controls, although satisfactory for rapid population screening
by national control programs, does not record additional im-
portant information for detailed research that may be required.
Taken together, these factors may explain why these genes
were not identified as differentially expressed. Within these
limitations, the results identify the major changes in gene
expression in this group of subjects and point to changes in
MMP7 as the major gene with altered expression.
Since MMP7 gene expression was upregulated in the TT
cases, we investigated whether the change would be reflected
in the proteins recovered from the same conjunctival samples.
The total protein showed some evidence of changes in the
abundance of proteins below 60 kDa. This result warrants
further study by two-dimensional SDS-PAGE. Using immuno-
blot analysis, we demonstrated the presence of MMP7, but
attempts to quantify the amount of protein by capture ELISA
were inhibited by the sample. The assay used to quantify
MMP7 was developed to be performed in the presence of
TIMP, the natural inhibitor of MMP7; thus, inhibition was due
to an unknown factor. The lack of differences in MMP7 in
pooled samples by immunoblot analysis may be masked the
natural biological variation of the samples and the semiquanti-
tative nature of immunoblot analysis techniques. Stimulation of
PBMCs from cases and controls with C. trachomatis EBs re-
sulted in a reduction in the inhibition of spontaneous produc-
tion of MMP7 in the cases compared with that in the controls
(i.e., higher levels of MMP7 remained in the supernatants of
cases after stimulation). This observation is difficult to interpret
and relate to the increased MMP7 gene expression observed in
the conjunctiva of the TT cases. However, PBMCs are a recog-
nized source of MMP7 in several studies, including the obser-
vation of differing levels of spontaneous production between
clinical groups.53,54
RT-PCR in 47 case–control pairs showed that TLR6 expres-
sion was reduced in TT cases, suggesting that the host’s rec-
ognition of bacterial ligands is affected in TT cases. Alterna-
tively, reduced TLR6 expression could be due to a reduced
number of TLR6-expressing cells or changes caused by the
disease process that result in the well-described increased
susceptibility to other bacterial infections.55 In the mouse,
reduced Tlr6 expression has been shown in macrophages on
stimulation with TNF or IFN,56 and a proinflammatory envi-
ronment has also been shown to reduce TLR6 expression in
epithelial cells.57
Reduced transcripts of two collagen proteins in subjects
with scarring trachoma suggest that the composition of the
extracellular matrix is altered. Collagen type I (COL1A1) and
VII (COL7A1) transcripts were downregulated in individuals
with TT. Many factors including cytokines affect expression of
COL1A1. TGF, IL-1, TNF, and IFN have all been shown to
affect expression of COL1A1.58 COL7A1 gene expression is
also regulated by proinflammatory cytokines (TNF, IL-1, and
TGF), expression is up- or downregulated depending on the
cell-type and the cytokines present,59,60 indicating a complex
biology. Transcription of COL7A1 is important in the formation
of anchoring fibrils, and this may play a role in the morphologic
changes that take place in the conjunctiva of subjects with
trichiasis.
C. trachomatis DNA was detected in only one individual,
consistent with the low prevalence of C. trachomatis infection
normally seen in subjects with TT in The Gambia and else-
where.61 We did not collect additional swabs for standard
microbial cultures. Publications in the literature suggest that
40% of subjects with TT are colonized with at least one
nonchlamydial bacterial species.62 The contribution of addi-
tional species and changes in the ocular microbiome are there-
fore important, since they directly influence the host’s expres-
sion profile and response to further challenge by infection.63
The altered PBMC response levels of MMP7 in trichiasis may be
a result of inherited genetic polymorphisms that predisposes
the host to inflammation-driven fibrosis. Investigation of the
signaling pathways and downstream targets of MMP7, along
with MMP7 polymorphisms (some of which have already been
identified as risk factors for fibrosis64,65), may yield important
information in the etiology of the scarring process.
We ultimately found four genes with altered expression:
MMP7, COL1A1, COL7A1, and TLR6. We accepted a high rate
of potential false-positive association when screening genes by
the array and subsequently during validation by qRT-PCR, since
the normal methods of correcting P-values and the general
applicability of adjusting for multiplicity of tests remain matters
of contention among biostatisticians.23,28 We therefore leave
our colleagues to balance the significance of the findings
against the interpretation of the study results. An independent
replication study with a larger number of subjects studied by
each method is the most appropriate manner of testing these
associations. We suggest that in geographic regions where
active trachoma and infection are hypoendemic, the C. tracho-
matis–specific adaptive and regulatory immune responses ex-
ert their major effect, if any, during the active stages of the
disease when conjunctival scarring is in its early stages. The
later stages of disease, such as those seen in adult TT cases,
which are characterized by innate proinflammatory and fi-
brotic responses, continue to progress once the inflammatory
environment is established and maintained by other non-
chlamydial inflammatory insults. In populations, where rapidly
advancing TS and TT can be observed in children and young
adults, the role of C. trachomatis–infection and the inflamma-
tory immune response in the acceleration of the disease pro-
cess requires closer inspection with longitudinal follow-up of
participants and repeated measures of gene expression.
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